Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced a dividend on Monday, November 5th, Fidelity reports. Shareholders of record on Tuesday, December 11th will be paid a dividend of 12.81 per share on Friday, December 28th. The ex-dividend date of this dividend is Monday, December 10th.
Shares of TARO stock traded up $1.60 on Wednesday, hitting $106.01. The stock had a trading volume of 66,248 shares, compared to its average volume of 44,333. Taro Pharmaceutical Industries has a twelve month low of $93.01 and a twelve month high of $121.23. The firm has a market capitalization of $4.25 billion, a price-to-earnings ratio of 17.15 and a beta of 0.29.
Taro Pharmaceutical Industries (NYSE:TARO) last announced its quarterly earnings results on Monday, November 5th. The company reported $1.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.96 by ($0.36). Taro Pharmaceutical Industries had a net margin of 36.33% and a return on equity of 11.99%. The firm had revenue of $158.97 million during the quarter, compared to analyst estimates of $167.40 million. Sell-side analysts predict that Taro Pharmaceutical Industries will post 7.65 earnings per share for the current year.
WARNING: This piece was first published by WKRB News and is the property of of WKRB News. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be accessed at https://www.wkrb13.com/2018/12/05/taro-pharmaceutical-industries-ltd-taro-announces-dividend-of-12-81.html.
About Taro Pharmaceutical Industries
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, engages in the development, manufacture, and marketing of pharmaceutical products in the United States, Canada, Israel, and internationally. It offers prescription and over-the-counter pharmaceutical products focusing on primary areas, including topical creams and ointments, liquids, capsules, and tablets in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories.
Recommended Story: 52-Week High/Low Prices For Stock Selection
Receive News & Ratings for Taro Pharmaceutical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taro Pharmaceutical Industries and related companies with MarketBeat.com's FREE daily email newsletter.